Correction: Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis

Correction: Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-12-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/12/12/e008806corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer analysis
by: Tappei Takada, et al.
Published: (2024-03-01)

Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis
by: Jin Xiong, et al.
Published: (2025-08-01)

Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
by: Charles Dolladille, et al.
Published: (2020-05-01)

Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System
by: Sean R. Miller, et al.
Published: (2024-11-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
by: Maria Luisa De Perna, et al.
Published: (2025-08-01)

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01)

Immune-related adverse events following checkpoint inhibitor treatment in head and neck cancers: A comprehensive review
by: Remi Kessler, et al.
Published: (2023-06-01)

The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment
by: Tianhang Zhang, et al.
Published: (2024-12-01)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01)

Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?
by: Carrie Ye, et al.
Published: (2024-07-01)

Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
by: Jonathan L Curry, et al.
Published: (2025-08-01)

Patterns of immune-related adverse events in patients treated with immune checkpoint inhibitors: a Brazilian real-world analysis
by: Maria Paula Furtado Santos, et al.
Published: (2022-12-01)

Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy
by: Arian Lasocki, et al.
Published: (2025-06-01)

Immune Checkpoint Inhibitor-Related Sjögren’s Syndrome: An Ocular Immune-Related Adverse Event
by: Hideki Fukuoka, et al.
Published: (2025-05-01)

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors
by: Lauren A Dalvin, et al.
Published: (2025-04-01)

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024-07-01)

Endoscopic findings of immune checkpoint inhibitor-related gastrointestinal adverse events
by: Min Kyu Kim, et al.
Published: (2024-11-01)

Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events
by: Antonio Di Muzio, et al.
Published: (2025-03-01)

Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study
by: Lisa H Butterfield, et al.
Published: (2025-05-01)

Cancer type-specific adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis
by: Xuhui Tong, et al.
Published: (2025-01-01)

Time dependent predictors of cardiac inflammatory adverse events in cancer patients receiving immune checkpoint inhibitors
by: Michael Sayer, et al.
Published: (2025-04-01)

Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)

Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer
by: Yifan Wang, et al.
Published: (2025-05-01)

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase
by: Alessandro Ceschi, et al.
Published: (2024-11-01)

Major Adverse Cardiovascular Events in Patients with Melanoma Receiving Immune Checkpoint Inhibitors
by: Juan I. Ruiz, et al.
Published: (2025-04-01)

Clinical characteristic analysis of immune checkpoint inhibitor-related pituitary adverse events
by: Yufan ZHENG, et al.
Published: (2025-08-01)

Enteritis of the ileal conduit as an adverse event related to immune checkpoint inhibitor use
by: Ko Kobayashi, et al.
Published: (2025-01-01)

Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors.
by: Jennifer M Kwan, et al.
Published: (2024-01-01)

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
by: Chiara Cremolini, et al.
Published: (2023-01-01)

Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis
by: Qimei Fang, et al.
Published: (2025-02-01)

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
by: A Daban, et al.
Published: (2023-12-01)

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors
by: Shaili Tapiavala, et al.
Published: (2025-08-01)

Correction: Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
Published: (2021-10-01)

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Incidence of severe adverse events in cancer patients after treatment with immune-checkpoint inhibitors during the COVID- 19 pandemic
by: Sakiko Kimura, et al.
Published: (2025-04-01)

Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan
by: Mc Neil Valencia, et al.
Published: (2025-03-01)

Endocrine adverse events of immune checkpoint inhibitors: results of a single-center study
by: E. V. Poddubskaya, et al.
Published: (2019-12-01)

Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events
by: Franck Carbonnel, et al.
Published: (2024-11-01)

Correction: Acute kidney injury in patients treated with immune checkpoint inhibitors
Published: (2023-04-01)